Search research articles
Contact Us
Filters
Showing results (101-110 of 109) with videos related to
Page
of 11
Sort By:
You have reached the last page of results.
This site can display upto 109 results.
Annals of Internal Medicine
|
March 6, 2013
Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average-risk adults: a nested case-control study
Chyke A Doubeni, Sheila Weinmann, Kenneth Adams, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 14, 2019
Transcriptomic Heterogeneity of Androgen Receptor Activity Defines a <i>de novo</i> low AR-Active Subclass in Treatment Naïve Primary Prostate Cancer
Daniel E Spratt, Mohammed Alshalalfa, Nick Fishbane, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 31, 2017
Individual Patient-Level Meta-Analysis of the Performance of the Decipher Genomic Classifier in High-Risk Men After Prostatectomy to Predict Development of Metastatic Disease
Daniel E Spratt, Kasra Yousefi, Samineh Deheshi, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 20, 2025
Limitations in the Application of Clinicopathologic Factors Alone in Predicting Radiation Benefit for Women With Low-Risk Ductal Carcinoma In Situ After Breast Conserving Surgery: The Impact of a 7-Gene Biosignature Based on 10-Year Ipsilateral Breast Recurrence Rates
Frank Vicini, Chirag Shah, Karuna Mittal, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 28, 2018
LSD1 activates a lethal prostate cancer gene network independently of its demethylase function
Archana Sehrawat, Lina Gao, Yuliang Wang, et al.
Prostate Cancer and Prostatic Diseases
|
April 2, 2020
Performance of clinicopathologic models in men with high risk localized prostate cancer: impact of a 22-gene genomic classifier
Jeffrey J Tosoian, Samuel R Birer, R Jeffrey Karnes, et al.
Nature Communications
|
May 13, 2022
MYC drives aggressive prostate cancer by disrupting transcriptional pause release at androgen receptor targets
Xintao Qiu, Nadia Boufaied, Tarek Hallal, et al.
Cancer Causes & Control : CCC
|
February 2, 2022
Quantifying cancer risk from exposures to medical imaging in the Risk of Pediatric and Adolescent Cancer Associated with Medical Imaging (RIC) Study: research methods and cohort profile
Marilyn L Kwan, Diana L Miglioretti, Erin J A Bowles, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 30, 2017
Development and Validation of a Novel Integrated Clinical-Genomic Risk Group Classification for Localized Prostate Cancer
Daniel E Spratt, Jingbin Zhang, María Santiago-Jiménez, et al.
Page
of 11
Search research articles
Search
Showing results (101-110 of 109) with videos related to
Sort By:
Page
of 11
You have reached the last page of results.
This site can display upto 109 results.
Annals of Internal Medicine
|
March 6, 2013
Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average-risk adults: a nested case-control study
Chyke A Doubeni, Sheila Weinmann, Kenneth Adams, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 14, 2019
Transcriptomic Heterogeneity of Androgen Receptor Activity Defines a <i>de novo</i> low AR-Active Subclass in Treatment Naïve Primary Prostate Cancer
Daniel E Spratt, Mohammed Alshalalfa, Nick Fishbane, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 31, 2017
Individual Patient-Level Meta-Analysis of the Performance of the Decipher Genomic Classifier in High-Risk Men After Prostatectomy to Predict Development of Metastatic Disease
Daniel E Spratt, Kasra Yousefi, Samineh Deheshi, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 20, 2025
Limitations in the Application of Clinicopathologic Factors Alone in Predicting Radiation Benefit for Women With Low-Risk Ductal Carcinoma In Situ After Breast Conserving Surgery: The Impact of a 7-Gene Biosignature Based on 10-Year Ipsilateral Breast Recurrence Rates
Frank Vicini, Chirag Shah, Karuna Mittal, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 28, 2018
LSD1 activates a lethal prostate cancer gene network independently of its demethylase function
Archana Sehrawat, Lina Gao, Yuliang Wang, et al.
Prostate Cancer and Prostatic Diseases
|
April 2, 2020
Performance of clinicopathologic models in men with high risk localized prostate cancer: impact of a 22-gene genomic classifier
Jeffrey J Tosoian, Samuel R Birer, R Jeffrey Karnes, et al.
Nature Communications
|
May 13, 2022
MYC drives aggressive prostate cancer by disrupting transcriptional pause release at androgen receptor targets
Xintao Qiu, Nadia Boufaied, Tarek Hallal, et al.
Cancer Causes & Control : CCC
|
February 2, 2022
Quantifying cancer risk from exposures to medical imaging in the Risk of Pediatric and Adolescent Cancer Associated with Medical Imaging (RIC) Study: research methods and cohort profile
Marilyn L Kwan, Diana L Miglioretti, Erin J A Bowles, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 30, 2017
Development and Validation of a Novel Integrated Clinical-Genomic Risk Group Classification for Localized Prostate Cancer
Daniel E Spratt, Jingbin Zhang, María Santiago-Jiménez, et al.
Page
of 11